Invention Grant
- Patent Title: Haptens of olanzapine
- Patent Title (中): 奥氮平半抗原
-
Application No.: US13970653Application Date: 2013-08-20
-
Publication No.: US09303041B2Publication Date: 2016-04-05
- Inventor: Matthew Garrett Donahue , Yong Gong , Rhys Salter , Eric Hryhorenko , Thomas R. DeCory , Bart Remmerie , Banumathi Sankaran
- Applicant: JANSSEN PHARMACEUTICA NV , Ortho-Clinical Diagnostics, Inc.
- Applicant Address: BE Beerse US NJ Raritan
- Assignee: Janssen Pharmaceutica NV,Ortho-Clinical Diagnostics, Inc.
- Current Assignee: Janssen Pharmaceutica NV,Ortho-Clinical Diagnostics, Inc.
- Current Assignee Address: BE Beerse US NJ Raritan
- Agency: Johnson & Johnson
- Agent Bernard F. Plantz
- Main IPC: A61K31/551
- IPC: A61K31/551 ; C07D495/04 ; A61K47/48 ; C07K14/47 ; C07K14/77
Abstract:
The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzapine. The invention also relates to conjugates of an olanzapine hapten and a protein.
Public/Granted literature
- US20140213766A1 HAPTENS OF OLANZIPINE Public/Granted day:2014-07-31
Information query
